Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on July 22, 2025
Nonprofit Hairy's Dog House Brings Comfort to Children & Families With Therapy Dog Visits and Heartbeat Stuffed Animals
NEW YORK, NY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Hairy's Dog House, a nonprofit organization dedicated to providing emotional support through therapy dog visits, has been named an official partner of the New Jersey Ronald McDonald Houses …
CMP Scientific’s CR3520 cIEF-MS Workflow Used in Biopharma Customer’s BLA Submission
Analytical data generated with CMP CE-MS technology included in a Biologics License Application to the U.S. FDA BROOKLYN, NY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- CMP Scientific is pleased to announce that its CR3520 cIEF-MS workflow was …
Oral Biofilms: A Hidden Driver of Heart Disease and More, Says Leading Dentist-Researcher
A new publication by Dr. Robert A. Horowitz underscores how dental plaque may play a silent but significant role in heart attacks SCARSDALE, NY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- A growing body of evidence shows that oral biofilms—the …
Little Hands by Shop Home Med Launches Crowdfunding Platform Help Families Afford Medical Equipment for Their Children
Little Hands by Shop Home Med Launches Crowdfunding Platform to Help Families Afford Medical Equipment for Their Children BROOKLYN, NY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- In a groundbreaking move to ease the financial burden faced by …
Job Research Foundation Announces Funding for Investigating Causes and Treatments of Rare Immunodeficiency Disorder
New Submission Guidelines in Place for Scientific Research Grants up to $200,000 NEW YORK, NY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Job Research Foundation, which seeks to help find a cure and treatments for Job Syndrome, has announced the …
Andros Launches NLP Score Report To Help Health Plans Navigate Provider Network Transformation
Andros launches the NLP Score Report—a 10-minute diagnostic to help health plans assess network maturity, align strategy, and drive smarter transformation. NEW YORK, NY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Andros, the leader in Network …
XORTX Completes Non-Brokered Private Placement of Units
Not For Distribution to United States News Wire Services or for Dissemination in the United States CALGARY, Alberta, July 22, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late- …
Pennant Announces Second Quarter 2025 Earnings Release and Call
EAGLE, Idaho, July 22, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its second quarter …
Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide
MOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be covered by UnitedHealthcare across all lines of business, including …
Flora Strengthens Executive Leadership with Key Appointments Across Product, Data, and Technology Teams
Flora Management, is proud to announce 3 major leadership appointments that further cement its position as a category-defining force in HIT innovation. NEW YORK CITY, NY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Flora Management, a leading …
Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences
VICTORIA, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …
Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025
ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …
DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer
Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, today …
DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines
Châtillon, France, le 22 juillet (22 :30 CEST) 2025 DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— CUSIP: 23306J309), …
STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025
DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 first quarter results at 9:00 a.m. ET on August 7, 2025. The conference …
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday, August …
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis 50 mg once-daily dose of obefazimod led to a …
Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on …
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025
WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to …
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
CANTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …